Igenica Biotherapeutics, Inc., a company focused on the discovery and development of innovative antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the company will present new data on ADCs utilizing its SNAP site-specific ADC linker technology at a plenary session of the 2015 World ADC Summit, being held October 26-29, 2014 in San Diego.
Help employers find you! Check out all the jobs and post your resume.
